Speaker illustration

Doctor Jonathan Tjerkaski

Karolinska Institute, Stockholm (Sweden)

Member of:

European Society of Cardiology

Comparison of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in myocardial infarction patients with type 2 diabetes

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Treatment of acute coronary syndromes in clinical practice


Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: The role of bleeding in determining antithrombotic treatment in acute coronary syndromes


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb